Design of the exhale airway stents for emphysema (EASE) trial: an endoscopic procedure for reducing hyperinflation
2011

EASE Trial: New Stents for Emphysema

Sample size: 450 publication 10 minutes Evidence: moderate

Author Information

Author(s): Pallav L Shah, Dirk-Jan Slebos, Paulo FG Cardoso, Edward J Cetti, Gerhard W Sybrecht, Joel D Cooper

Primary Institution: Royal Brompton Hospital, Imperial College London

Hypothesis

Can Exhale® Drug-Eluting Stents improve pulmonary function and reduce breathlessness in patients with severe hyperinflation due to emphysema?

Conclusion

The EASE Trial aims to determine if a new bronchoscopic procedure can help emphysema patients breathe better and feel less short of breath.

Supporting Evidence

  • Over 3.7 million adults in the US are diagnosed with emphysema.
  • The trial uses Bayesian statistics for sample size determination.
  • Subjects undergo 16-20 sessions of supervised pulmonary rehabilitation before randomization.
  • Safety and effectiveness endpoints are measured at 6 months post-procedure.
  • Previous studies showed significant improvements in pulmonary function with stent placement.

Takeaway

Doctors are testing a new way to help people with a serious lung disease feel better by using special stents to open up their airways.

Methodology

A multi-center, randomized, double-blind, sham-controlled trial with 225 to 450 subjects receiving either the stent or sham treatment.

Potential Biases

The randomization ratio may introduce a placebo effect.

Limitations

Potential electrical interference from devices like pacemakers may exclude some patients.

Participant Demographics

Subjects are adults aged 35 and older with severe homogeneous emphysema.

Statistical Information

P-Value

p = 0.04

Statistical Significance

p<0.05

Digital Object Identifier (DOI)

10.1186/1471-2466-11-1

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication